Ticagrelor Reliable quality Buy 274693-27-5 274693-27-5 wholesaler CAS NO.274693-27-5

Ticagrelor Reliable quality Buy 274693-27-5 wholesaler

Ticagrelor is a high affinity and reversible P2Y₁₂ antagonist (pK_i = 8.7) that displays inverse agonism in 1321N1 cells. Also high affinity inhibitor of equilibrative nucleoside transporter 1 (ENT1; K_i = 41 nM). Inhibits ADP-induced platelet aggregation.

Our service:

1. High quality with competitive price:
We are manufacturer and we have 2 factories in China,we can provide excellent quality products with factory price.

2. Fast and safe delivery:
1) Parcels can be sent out within 3 days after payment. Tracking number is available.
2) Secure and discreet shipment. You have various choices of transportation methods.

3. We have clients throughout the world:
1) Professional service and rich experience make customers feel at ease, adequate stock and fast delivery meet your desire.
2) Market feedback and goods feedback are appreciated, meeting customers's requirement is our  responsibility.
3) High quality, competitive price, fast delivery, first-class service gain the trust and praise from the customers.

4. Exported areas:

Europe , southeast Asia , the Middle East , Africa , South America and some other countries and areas.
 
5. We manufacture Herbal Extract and Active Pharmaceutical Ingredients products.

Business scope: the pharmaceutical industry with professional import&export services of APIs and Intermediates as well as Herbal Extracts.

About us:

Hunan Warner Pharmaceutical Co., Ltd. is an innovation-leading pharmaceutical manufacturer. Since the company was founded in 2001, adhering to the "science and technology service health" of the enterprise purpose, adhere to the "great concentration pharmaceutical, treat people good faith" the management idea, taking the path of specialization, preliminary finished from chemical API to chemical medicine preparations, from medicinal plant, plant extraction and separation to traditional Chinese medicine preparations such as medicine, Chinese medicine two industrial chain system planning and construction of form a complete set, Research and development, production and sales in chemical medicine, traditional Chinese medicine and other fields coordinated and orderly development.

Since the establishment of the company in 2001, the company has made use of its own capital, talent, information and new drug research and development advantages, on the one hand, focusing on the research and development of new drugs, in a relatively short period of time to complete a series of new drug research and development work. With zhejiang sea is pharmaceutical co., LTD., China medicine group pharmaceutical co., LTD, hainan and brent pharmaceutical co., LTD., keep love some domestic well-known enterprises such as blessed pharmaceutical co., LTD. Signed a number of technology transfer agreement, from 2001 to now realized total technology transfer contract amount is 16.1 million yuan, become a rising star in the field of new drug technology development in hunan province. On the other hand, the company strengthens the construction of production facilities. With the approval of Hunan Provincial Drug Administration, the company has set up a modern production workshop in Liuyang Biological Medicine Park that meets the requirements of GMP. The first-phase project investment is more than 20 million yuan. A solid preparation workshop with an annual production capacity of 200 million tablets, 200 million capsules and 50 million packets of granules and an active drug production workshop with an annual production capacity of 500 tons (mainly producing active drug disodium hydrogen phosphate and sodium dihydrogen phosphate) has been built. In December 2003, all the production workshops of the company have passed the national GMP on-site inspection and obtained the GMP certificate

Process Capability :   The facilities are designed and operated in a manner consistent with GMP,and well maintained at all times in good working order through inspections and the preventive maintenance program.Appropriate cleaning procedures and validation are in place to prevent cross-contamination,especially in facilities where multiple pharmaceutical grade products are processed. Most of our APIs and all formulation production lines are new GMP certified

Product Description